Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Analysis of Seroma and Hematoma Rates: MAXIGESIC vs. Ketorolac in Breast Cancer Surgery Patients

NCT06575049 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT06575049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06575049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Analysis of Seroma and Hematoma Rates: MAXIGESIC vs. Ketorolac in Breast Cancer Surgery Patients
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
May 1, 2025
Completion date
February 20, 2026
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, post-op complication, post-operative hematoma, seroma as procedural complication